120
Participants
Start Date
September 11, 2024
Primary Completion Date
August 18, 2026
Study Completion Date
October 15, 2026
Ketamine Hydrochloride
Participants will receive IV ketamine (0.50mg/kg) dissolved in 0.9% sodium chloride in a total volume of 100mL and administered with an infusion pump over 45 minutes. Duration of each infusion may be extended by the Study Clinician supervising study medication infusion if slower infusion rate is better tolerated.
Midazolam Hydrochloride
Participants will receive IV midazolam (0.02mg/kg) dissolved in 0.9% sodium chloride in a total volume of 100mL and administered with an infusion pump over 45 minutes. Duration of each infusion may be extended by the Study Clinician supervising study medication infusion if slower infusion rate is better tolerated.
TERMINATED
Addiction Institute of Mount Sinai, New York
RECRUITING
Prisma Health, Greenville
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
Interdisciplinary Substance Use and Brain Injury Facility, Albuquerque
University of Texas Southwestern Medical Center
OTHER